Breaking News

Bioniche Names COO

By Kristin Brooks | January 8, 2014

Olds brings scientific, operational, and financial experience

Donald Olds has been appointed chief operating officer at Bioniche Life Sciences. Prior to joining the company, Mr. Olds held key executive positions in biotechnology, investment banking, biotechnology and IT, and has led successful licensing, merger and acquisition and debt and equity transactions. He currently serves as chairman of the board of the Neomed Institute, director and chair of the Audit Committee of the Centre Quebecois, director of Bellus Health, and is treasurer of Oxfam Quebec.
Dr. Michael Berendt, chief executive officer of Bioniche Life Sciences Inc., said, "The engagement of Donald Olds is the next step in our operational plan to position Bioniche Life Sciences as a top-tier North American biotechnology company with a focus on the development of oncology therapeutics. Don brings a rare combination of scientific, operational, and financial acumen that we are confident will help us position our human therapeutic business for future success and permit us to achieve our other operational objectives, including the licensing and divestiture of our non-core business assets and the implementation of operating cost reductions."
blog comments powered by Disqus
  • The Role of Value in Drug Pricing

    The Role of Value in Drug Pricing

    Keren Shani, Ryan Million, Trinity Partners ||October 11, 2016
    Exploring the trend of using frameworks and models to evaluate the value of a drug

  • CRO-Sponsor Partnerships

    CRO-Sponsor Partnerships

    Craig Morgan, Brand Development Director, goBalto Inc.||October 11, 2016
    10 tips for enabling better CRO and sponsor collaborations

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus